Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

Supplier of Active Pharmaceutical Ingredient (API) – Promethazine Hydrochloride

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract pertains to the supply of USP-grade promethazine hydrochloride active pharmaceutical ingredient for use in the final formulation of a pharmaceutical product, specifically under a subcontract arrangement. The procurement is managed by the Defense Logistics Agency within the Department of Defense, with the NAICS code 325411 indicating classification under pharmaceutical and biological product manufacturing. Although the solicitation number and specific point of contact are not provided, the posting date is August 9, 2026, and the performance location details are unspecified. The API must meet United States Pharmacopeia standards to ensure quality and compliance with regulatory requirements for drug manufacturing. The contract reference number SPE2DX25D8022 and delivery identifier SPE2D926F8075 are linked through the DIBBS system, facilitating tracking and award administration for the supplier.

General Info

Supply of USP-grade promethazine hydrochloride API for DoD pharmaceutical use under contract SPE2DX25D8022.

Agency

Department Of Defense → Defense Logistics AgencyView Agency

NAICS

325411 - Medicinal and Botanical ManufacturingView NAICS

Place of Performance

Not specified

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Logistics Agency
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Defense → Defense Logistics Agency
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Supply of USP-grade promethazine hydrochloride API for use in final drug formulation.

Similar Contracts

Same NAICS industry code

NAICS: 325411
New
DIBBS
BENZOCAINE AND MENTHOL
Solicitation # SPE2DP-26-T-4585
The contract pertains to the procurement of Benzocaine and Menthol Lozenge, specifically CEPACOL EXTRA STRENGTH SORE THROAT HONEY LEMON LOZENGES, containing 15 mg of benzocaine and 2.6 mg of menthol per lozenge, supplied in a package of 16 lozenges. The product must be stored at 20–25°C (68–77°F) and protected from humidity to maintain efficacy. Packaging and labeling must comply with Medical Marking Standard No. 1, which supersedes MIL-STD-129, and all units must be sealed in suitable containers to prevent damage or breakage, with exterior shipping containers meeting commercial standards for safe, low-cost delivery to the specified destination. The item is classified as a TYPE I (CODE Q) with a non-extendable shelf life of 36 months, and all packaging must adhere to DLA’s packaging requirements and palletization standards. The product’s NDC is 63824-0732-16, supplied by RB HEALTH US LLC, and is identified by NSN 6505-01-708-1449. The contract requires delivery of six packages within five days of the award, with FOB destination as the delivery point and no variance allowed in quantity. Inspection and acceptance occur at the delivery location. The shipment must be sent by the fastest traceable means, excluding parcel post, to the designated military address at Fort Stewart, Georgia, marked for W33RBS with the provided military identifier and tracking code. The solicitation number is SPE2DP-26-T-4585, issued under the Department of Defense’s Medical Supply Chain, with a response deadline of August 17, 2026, and an original required delivery date of August 12, 2026. Technical and quality compliance is governed by the DLA Master List of Technical and Quality Requirements, and the item falls under the NAICS code 325411 for pharmaceutical preparation manufacturing. All markings, packaging, and documentation must strictly follow the specified standards to ensure compliance and seamless integration into military medical supply systems.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 7 hours ago

DEADLINE

in 7 days
View Details
NAICS: 325411
New
DIBBS
CALCIUM CHLORIDE INJEC
Solicitation # SPE2DP-26-T-4471
CALCIUM CHLORIDE INJECTION USP is procured as a 10 mL single-dose plastic syringe containing 1 gram of calcium chloride (100 mg/mL), packaged ten syringes per unit (1 PG = 10 EA), with a mandatory 24-month shelf life from the date of manufacture, no less than 21 months of which must remain at the time of delivery to the government. The product must be labeled in strict accordance with Medical Marking Standard No. 1, including the NSN, manufacturer, CAGE code, date of manufacture, expiration or retest date, contract number, and lot number, and stored at 20 to 25°C (68 to 77°F). The item is regulated by the FDA and requires prior confirmation from the product specialist via EBS referral before award. Packaging must be commercial and designed to protect against damage, with exterior shipping containers ensuring safe, cost-effective transport to the delivery point. All packaging and marking must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and palletization must follow DLA Packaging Requirements for Procurement. The manufacturer is Pfizer Inc, with NDC 00409-1631-10, and the item is identified by NSN 6505-01-655-0700. Delivery is FOB destination in 20 days to Fort Campbell, Kentucky, with zero quantity variance permitted, and shipment must occur via traceable means, excluding parcel post. The contract reference is SPE2DP-26-T-4471, with an original required delivery date of August 5, 2026, and procurement governed by the DLA Master List of Technical and Quality Requirements, which take precedence over all other standards including ASTM D3951.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

6 days ago

DEADLINE

in about 4 hours
View Details
NAICS: 325411
DIBBS
LIDOCAINE HYDROCHLO
Solicitation # SPE2DP-26-T-4430
The contract specifies the procurement of LidoCaine Hydrochloride 2% Mucosal Jelly in single-use prefilled plastic syringes, each containing 220 mg per 11 mL, packaged in boxes of ten units. The product is a sterile topical anesthetic intended for medical use, with a non-extendable shelf life of 36 months and must comply with the Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must meet commercial standards as defined in the procurement document, ensuring each unit is sealed and protected from damage, and shipped in commercial exterior containers that guarantee safe delivery at the lowest cost to the designated destination. The item is identified by NSN 6505-01-707-4169 and NDC 25021-0673-77, supplied by Sagent Pharmaceuticals, Inc., and the unit of issue is one box containing ten syringes. Delivery is required within five days FOB destination, with no variance permitted in quantity, and inspection and acceptance occur at the delivery point. The shipment is directed to USMC facilities in Palmerston, Australia, under a SOFA tariff agreement, with specific transportation and marking instructions governed by DLA procedures. The contract was issued under solicitation SPE2DP-26-T-4430, with a response deadline in August 2026, and is managed by the Department of Defense’s Medical Supply Chain Pharm FSA, with Timothy McCauley listed as the primary point of contact.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

8 days ago

DEADLINE

in about 4 hours
View Details
NAICS: 325411
DIBBS
PSYLLIUM HYDROPHILI
Solicitation # SPE2DP-26-T-4403
The contract is for Psyllium Hydrophilic Mucilloid in 12 gm packets, each containing 25 mg potassium and 5 mg sodium, sold in units of 30 packets per package, with a total quantity of 10 packages required. The product, identified by NSN 6505-01-719-3181 and manufacturer part number NDC37000-0740-87 from Procter & Gamble Distributing LLC, is regulated by the FDA and must comply with all applicable medical and packaging standards, including the Medical Marking Standard No. 1, which supersedes MIL-STD-129 for this item. The product has a non-extendable shelf life of 24 months under Type I (Code M) requirements, and all packaging must meet DLA’s commercial packaging and protection standards as outlined in MIL-STD-2073-1E and RP001, ensuring secure, carrier-acceptable delivery to the destination. Delivery is required FOB destination within 79 days of contract award, with no tolerance for quantity variance, and the item must be marked and packed strictly according to specified medical and defense logistics guidelines. The contract identifies the delivery point as APO AP 96260-5479, with the final destination at Camp Carroll, Korea, and the original required delivery date is December 17, 2025. Bidders must provide the exact source and part number being offered and are subject to FDA referral through EBS prior to award. All documentation and compliance are governed by the DLA Master List of Technical and Quality Requirements in effect on the solicitation issue date, and transport arrangements must follow DLAD Proc Notes C19 and C20. The solicitation, issued under contract number SPE2DP-26-T-4403, has a response deadline of August 10, 2026.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

8 days ago

DEADLINE

in about 4 hours
View Details
NAICS: 325411
International
Supply of High-Protein Nutritional SupplementsThe contract is for the supply of high-protein nutritional supplements designed to meet the therapeutic needs of malnourished individuals and those recovering from surgery, ensuring they receive essential protein-enriched medical foods to support recovery and overall health. The product must be formulated specifically for clinical use, delivering precise nutritional profiles to address deficiencies and promote healing in vulnerable patient populations under medical supervision. The agreement is structured as a subcontract and falls under the NAICS code 325411, indicating classification within pharmaceutical and pharmaceutical preparation manufacturing. The contracting authority is the South East Regional Health Authority under the Government of Jamaica, with the solicitation posted on July 30, 2026, and the supplies to be delivered to locations within Jamaica’s south eastern region. The contract does not involve a set-aside designation, and detailed performance location or point of contact information is not provided. All deliveries must align with medical standards for therapeutic nutrition, and the successful vendor will be expected to maintain consistent quality, regulatory compliance, and timely fulfillment to support ongoing patient care programs across the region. Access to further details is available through the official government e-procurement portal.
South East Regional Health Authority

POSTED

11 days ago

DEADLINE

N/A
View Details
NAICS: 325411
International
Supply of Pediatric Nutritional FormulasThe contract entails the supply of specialized infant and pediatric nutritional products designed to support growth and address specific medical conditions in children’s hospital settings. These include growth-support formulas and condition-specific medical nutritionals tailored for neonatal and pediatric patients, ensuring appropriate dietary intervention for those with unique nutritional needs due to illness, prematurity, or developmental challenges. The scope is focused exclusively on delivering high-quality, medically validated products to healthcare facilities under the jurisdiction of the South East Regional Health Authority in Jamaica. The agreement is structured as a subcontract and falls under the NAICS code 325411, indicating classification within pharmaceutical and medicine manufacturing. It was posted on July 30, 2026, and is administered by the Government of Jamaica through its regional health authority. While no specific place of performance or point of contact is detailed, the products are intended for use within children’s hospitals served by the authority, and all deliveries must meet stringent healthcare standards to ensure patient safety and efficacy. The contract does not specify a set-aside designation, and potential suppliers must comply with regulatory and quality requirements applicable to infant and pediatric medical nutritionals in Jamaica.
South East Regional Health Authority

POSTED

11 days ago

DEADLINE

N/A
View Details

More opportunities from Department Of Defense → Defense Logistics Agency

Same awarding agency